Cadrenal Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 50.14 K | $167.46 K | 10.92% | 1.72% |
| HRT FINANCIAL LP | 08/14/2026 | 29.06 K | $97.00 K | 100.00% | 1.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 19.02 K | $63.54 K | -12.03% | 0.65% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 8.31 K | $27.76 K | 0.00% | 0.29% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/11/2026 | 1.28 K | $4.28 K | 226.21% | 0.04% |
| UBS GROUP AG | 08/13/2026 | 1.11 K | $3.71 K | 36,966.67% | 0.04% |
| GROVE BANK & TRUST | 07/07/2026 | 1.00 K | $3.34 K | 100.00% | 0.03% |
| MORGAN STANLEY | 08/13/2026 | 706 | $2.36 K | 606.00% | 0.02% |
| CLEARSTEAD ADVISORS, LLC | 08/06/2026 | 650 | $2.17 K | 100.00% | 0.02% |
| QUEST 10 WEALTH BUILDERS, INC. | 07/24/2026 | 380 | $1.27 K | 100.00% | 0.01% |
| ADVISOR GROUP HOLDINGS, INC. | 08/14/2026 | 300 | $1.00 K | 0.00% | 0.01% |
| ROCKEFELLER CAPITAL MANAGEMENT L.P. | 08/13/2026 | 150 | $501 | 0.00% | 0.01% |
| WELLS FARGO & COMPANY/MN | 08/14/2026 | 99 | $331 | 0.00% | 0.00% |
| BARCLAYS PLC | 08/14/2026 | 93 | $311 | 100.00% | 0.00% |
| INTEGRATED WEALTH CONCEPTS LLC | 08/12/2026 | 86 | $287 | 100.00% | 0.00% |
| ARCHER INVESTMENT CORP | 08/19/2026 | 35 | $117 | 0.00% | 0.00% |
| IFP ADVISORS, INC | 07/20/2026 | 30 | $100 | 0.00% | 0.00% |
| JPMORGAN CHASE & CO | 08/12/2026 | 0 | $0 | -100.00% | 0.00% |
| CITIGROUP INC | 08/03/2026 | 0 | $0 | -100.00% | 0.00% |
| DESTINY WEALTH PARTNERS, LLC | 08/07/2026 | 0 | $0 | -100.00% | 0.00% |
| BLACKROCK, INC. | 08/07/2026 | 0 | $0 | -100.00% | 0.00% |
| CURIO WEALTH, LLC | 08/07/2026 | 0 | $0 | -100.00% | 0.00% |
| CYGNUS CAPITAL ADVISORS, LLC | 09/03/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Cadrenal Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 24 institutional investors and hedge funds held shares of Cadrenal Therapeutics Inc. The most heavily invested institutionals were:
VANGUARD CAPITAL MANAGEMENT LLC: 50,137
HRT FINANCIAL LP: 29,055
GEODE CAPITAL MANAGEMENT, LLC: 19,024
VANGUARD FIDUCIARY TRUST CO: 8,311
Tower Research Capital LLC (TRC): 1,282
UBS Group AG: 1,112
3.86% of Cadrenal Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 166.36 K shares in the last 24 months. This purchase volume represents approximately $1.33 M in transactions.